Christopher Locher
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$4.0MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $4.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 11, 2026 | NIH | SBIR Phase II Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria Vaccine | $1000K | VERSATOPE THERAPEUTICS, INC. |
| Nov 1, 2024 | NIH | SBIR Phase II Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria Vaccine | $1000K | VERSATOPE THERAPEUTICS, INC. |
| Dec 8, 2023 | NIH | SBIR Phase II Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria Vaccine | $1000K | VERSATOPE THERAPEUTICS, INC. |
| Aug 11, 2020 | NIH | SBIR Phase I Novel C. Difficile Vaccine Using Nano-vesicle Delivery System | $300K | VERSATOPE THERAPEUTICS, INC. |
| Sep 1, 2019 | NIH | SBIR Phase I Multivalent influenza vaccine using exosomes from probiotic E. coli | $225K | VERSATOPE THERAPEUTICS, INC. |
| Apr 5, 2019 | NIH | SBIR Phase I Multivalent influenza vaccine using recombinant outer membrane vesicles | $225K | VERSATOPE THERAPEUTICS, INC. |
| Mar 5, 2018 | NIH | SBIR Phase I Universal Influenza Vaccine | $225K | VERSATOPE THERAPEUTICS, INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#402
Awards as PI#250
Patents#273
Companies
- VERSATOPE THERAPEUTICS, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.